Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival

Xiaoyun Liao, Paul Lochhead, Reiko Nishihara, Teppei Morikawa, Aya Kuchiba, Mai Yamauchi, Yu Imamura, Zhi Rong Qian, Yoshifumi Baba, Kaori Shima, Ruifang Sun, Katsuhiko Nosho, Jeffrey A. Meyerhardt, Edward Giovannucci, Charles S. Fuchs, Andrew T. Chan, Shuji Ogino

Research output: Contribution to journalArticle

536 Citations (Scopus)

Abstract

Regular use of aspirin after a diagnosis of colon cancer has been associated with a superior clinical outcome. Experimental evidence suggests that inhibition of prostaglandin-endoperoxide synthase 2 (PTGS2) (also known as cyclooxygenase-2) by aspirin down-regulates phosphatidylinositol 3-kinase (PI3K) signaling activity. We hypothesized that the effect of aspirin on survival and prognosis in patients with cancers characterized by mutated PIK3CA (the phosphatidylinositol-4,5-bisphosphonate 3-kinase, catalytic subunit alpha polypeptide gene) might differ from the effect among those with wild-type PIK3CA cancers.
Original languageEnglish
Pages (from-to)1596-1606
Number of pages11
JournalThe New England Journal of Medicine
Volume367
Issue number17
DOIs
Publication statusPublished - 25 Oct 2012

Fingerprint

Aspirin
Colorectal Neoplasms
Mutation
Survival
Phosphatidylinositol 3-Kinase
Neoplasms
Diphosphonates
Cyclooxygenase 2
Prostaglandin-Endoperoxide Synthases
Phosphatidylinositols
Colonic Neoplasms
Catalytic Domain
Phosphotransferases
Down-Regulation
Peptides
Genes

Cite this

Liao, X., Lochhead, P., Nishihara, R., Morikawa, T., Kuchiba, A., Yamauchi, M., ... Ogino, S. (2012). Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. The New England Journal of Medicine, 367(17), 1596-1606. https://doi.org/10.1056/NEJMoa1207756

Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. / Liao, Xiaoyun; Lochhead, Paul; Nishihara, Reiko; Morikawa, Teppei; Kuchiba, Aya; Yamauchi, Mai; Imamura, Yu; Qian, Zhi Rong; Baba, Yoshifumi; Shima, Kaori; Sun, Ruifang; Nosho, Katsuhiko; Meyerhardt, Jeffrey A.; Giovannucci, Edward; Fuchs, Charles S.; Chan, Andrew T.; Ogino, Shuji.

In: The New England Journal of Medicine, Vol. 367, No. 17, 25.10.2012, p. 1596-1606.

Research output: Contribution to journalArticle

Liao, X, Lochhead, P, Nishihara, R, Morikawa, T, Kuchiba, A, Yamauchi, M, Imamura, Y, Qian, ZR, Baba, Y, Shima, K, Sun, R, Nosho, K, Meyerhardt, JA, Giovannucci, E, Fuchs, CS, Chan, AT & Ogino, S 2012, 'Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival', The New England Journal of Medicine, vol. 367, no. 17, pp. 1596-1606. https://doi.org/10.1056/NEJMoa1207756
Liao X, Lochhead P, Nishihara R, Morikawa T, Kuchiba A, Yamauchi M et al. Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. The New England Journal of Medicine. 2012 Oct 25;367(17):1596-1606. https://doi.org/10.1056/NEJMoa1207756
Liao, Xiaoyun ; Lochhead, Paul ; Nishihara, Reiko ; Morikawa, Teppei ; Kuchiba, Aya ; Yamauchi, Mai ; Imamura, Yu ; Qian, Zhi Rong ; Baba, Yoshifumi ; Shima, Kaori ; Sun, Ruifang ; Nosho, Katsuhiko ; Meyerhardt, Jeffrey A. ; Giovannucci, Edward ; Fuchs, Charles S. ; Chan, Andrew T. ; Ogino, Shuji. / Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. In: The New England Journal of Medicine. 2012 ; Vol. 367, No. 17. pp. 1596-1606.
@article{4b6c1835aca04e999de32e5b57dae79b,
title = "Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival",
abstract = "Regular use of aspirin after a diagnosis of colon cancer has been associated with a superior clinical outcome. Experimental evidence suggests that inhibition of prostaglandin-endoperoxide synthase 2 (PTGS2) (also known as cyclooxygenase-2) by aspirin down-regulates phosphatidylinositol 3-kinase (PI3K) signaling activity. We hypothesized that the effect of aspirin on survival and prognosis in patients with cancers characterized by mutated PIK3CA (the phosphatidylinositol-4,5-bisphosphonate 3-kinase, catalytic subunit alpha polypeptide gene) might differ from the effect among those with wild-type PIK3CA cancers.",
author = "Xiaoyun Liao and Paul Lochhead and Reiko Nishihara and Teppei Morikawa and Aya Kuchiba and Mai Yamauchi and Yu Imamura and Qian, {Zhi Rong} and Yoshifumi Baba and Kaori Shima and Ruifang Sun and Katsuhiko Nosho and Meyerhardt, {Jeffrey A.} and Edward Giovannucci and Fuchs, {Charles S.} and Chan, {Andrew T.} and Shuji Ogino",
note = "PMID: 23094721 [PubMed - indexed for MEDLINE] PMCID: PMC3532946 Free PMC Article",
year = "2012",
month = "10",
day = "25",
doi = "10.1056/NEJMoa1207756",
language = "English",
volume = "367",
pages = "1596--1606",
journal = "The New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "17",

}

TY - JOUR

T1 - Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival

AU - Liao, Xiaoyun

AU - Lochhead, Paul

AU - Nishihara, Reiko

AU - Morikawa, Teppei

AU - Kuchiba, Aya

AU - Yamauchi, Mai

AU - Imamura, Yu

AU - Qian, Zhi Rong

AU - Baba, Yoshifumi

AU - Shima, Kaori

AU - Sun, Ruifang

AU - Nosho, Katsuhiko

AU - Meyerhardt, Jeffrey A.

AU - Giovannucci, Edward

AU - Fuchs, Charles S.

AU - Chan, Andrew T.

AU - Ogino, Shuji

N1 - PMID: 23094721 [PubMed - indexed for MEDLINE] PMCID: PMC3532946 Free PMC Article

PY - 2012/10/25

Y1 - 2012/10/25

N2 - Regular use of aspirin after a diagnosis of colon cancer has been associated with a superior clinical outcome. Experimental evidence suggests that inhibition of prostaglandin-endoperoxide synthase 2 (PTGS2) (also known as cyclooxygenase-2) by aspirin down-regulates phosphatidylinositol 3-kinase (PI3K) signaling activity. We hypothesized that the effect of aspirin on survival and prognosis in patients with cancers characterized by mutated PIK3CA (the phosphatidylinositol-4,5-bisphosphonate 3-kinase, catalytic subunit alpha polypeptide gene) might differ from the effect among those with wild-type PIK3CA cancers.

AB - Regular use of aspirin after a diagnosis of colon cancer has been associated with a superior clinical outcome. Experimental evidence suggests that inhibition of prostaglandin-endoperoxide synthase 2 (PTGS2) (also known as cyclooxygenase-2) by aspirin down-regulates phosphatidylinositol 3-kinase (PI3K) signaling activity. We hypothesized that the effect of aspirin on survival and prognosis in patients with cancers characterized by mutated PIK3CA (the phosphatidylinositol-4,5-bisphosphonate 3-kinase, catalytic subunit alpha polypeptide gene) might differ from the effect among those with wild-type PIK3CA cancers.

U2 - 10.1056/NEJMoa1207756

DO - 10.1056/NEJMoa1207756

M3 - Article

C2 - 23094721

VL - 367

SP - 1596

EP - 1606

JO - The New England Journal of Medicine

JF - The New England Journal of Medicine

SN - 0028-4793

IS - 17

ER -